相关实验视频

Updated: Jun 27, 2025

Identifying PD-1/PD-L1 Inhibitors with Surface Plasmon Resonance Technology
07:04

Identifying PD-1/PD-L1 Inhibitors with Surface Plasmon Resonance Technology

Published on: May 2, 2025

298

针对PD-L1的小分子抑制剂的进展

Jindan Xu1,2,3, Yuanfang Kong1, Pengbo Zhu1,2,3

  • 1Henan University of Chinese Medicine Zhengzhou 450046 Henan China tongyan1974@126.com arphylee@126.com chunhong_dong@hactcm.edu.cn.

RSC medicinal chemistry
|April 26, 2024
PubMed
概括

针对编程细胞死亡配体1 (PD-L1) 的小分子抑制剂为癌症免疫治疗提供了抗体的替代方案. 本综述总结了小分子PD-L1抑制剂的最新进展,有助于未来的药物设计.

更多相关视频

Development of a 68Gallium-Labeled D-Peptide PET Tracer for Imaging Programmed Death-Ligand 1 Expression09:06

Development of a 68Gallium-Labeled D-Peptide PET Tracer for Imaging Programmed Death-Ligand 1 Expression

Published on: February 3, 2023

1.5K
Using 22C3 Anti-PD-L1 Antibody Concentrate on Biopsy and Cytology Samples from Non-small Cell Lung Cancer Patients07:43

Using 22C3 Anti-PD-L1 Antibody Concentrate on Biopsy and Cytology Samples from Non-small Cell Lung Cancer Patients

Published on: September 25, 2018

10.6K

相关概念视频

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.6K